Published in Genet Med on December 01, 2006
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med (2010) 1.12
Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am J Epidemiol (2010) 1.05
Influence of family history of diabetes on health care provider practice and patient behavior among nondiabetic Oregonians. Prev Chronic Dis (2008) 0.94
Correlating pharmaceutical data with a national health survey as a proxy for estimating rural population health. Popul Health Metr (2010) 0.90
Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention. Diabetes Res Clin Pract (2012) 0.89
Veterans' experience in using the online Surgeon General's family health history tool. Per Med (2011) 0.86
Impact of a Booklet about Diabetes Genetic Susceptibility and Its Prevention on Attitudes towards Prevention and Perceived Behavioral Change in Patients with Type 2 Diabetes and Their Offspring. Adv Prev Med (2010) 0.85
Steroid-induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol (2012) 0.84
Reducing health risk in family members of patients with type 2 diabetes: views of first degree relatives. BMC Public Health (2009) 0.82
Family history as a predictor for disease risk in healthy individuals: a cross-sectional study in Slovenia. PLoS One (2013) 0.79
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med (2007) 9.48
Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10
Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med (2011) 8.48
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol (2006) 7.66
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
A navigator for human genome epidemiology. Nat Genet (2008) 5.07
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53
How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol (2005) 4.46
Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010. MMWR Surveill Summ (2011) 4.43
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 4.22
Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76
National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health (2012) 3.72
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
Recommendations for returning genomic incidental findings? We need to talk! Genet Med (2013) 3.23
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
What is the clinical utility of genetic testing? Genet Med (2006) 3.01
Institutional and economic determinants of public health system performance. Am J Public Health (2006) 3.01
Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med (2003) 2.99
Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics (2012) 2.75
Improving validation practices in "omics" research. Science (2011) 2.73
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health (2010) 2.43
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med (2007) 2.34
Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34
Most published research findings are false-but a little replication goes a long way. PLoS Med (2007) 2.26
Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care (2007) 2.22
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med (2009) 2.17
DNA banking for epidemiologic studies: a review of current practices. Epidemiology (2002) 2.16
The path from genome-based research to population health: development of an international public health genomics network. Genet Med (2006) 2.15
Invited commentary: genes, environment, and hybrid vigor. Am J Epidemiol (2009) 2.15
Associations between sleep disorders, sleep duration, quality of sleep, and hypertension: results from the National Health and Nutrition Examination Survey, 2005 to 2008. J Clin Hypertens (Greenwich) (2011) 2.15
Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet (2003) 2.11
Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr (2003) 2.11
Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA (2009) 2.10
Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol (2015) 2.04
Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med (2010) 1.98
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet (2003) 1.85
Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care (2003) 1.84
Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis (2005) 1.84
Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A (2008) 1.84
Potentially preventable deaths from the five leading causes of death--United States, 2008-2010. MMWR Morb Mortal Wkly Rep (2014) 1.83
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology (2003) 1.82
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med (2011) 1.80
From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Pediatrics (2006) 1.77
Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med (2006) 1.77
GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75
The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol (2014) 1.73
"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev (2013) 1.72
Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet (2011) 1.69
Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol (2006) 1.67
Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med (2006) 1.67
Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak (2010) 1.66
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet (2009) 1.62
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Rationale for regular reporting on health disparities and inequalities - United States. MMWR Surveill Summ (2011) 1.61
Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol (2008) 1.53
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
Getting what you pay for: public health spending and the performance of essential public health services. J Public Health Manag Pract (2004) 1.45
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med (2006) 1.43
Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence. BMC Public Health (2010) 1.42
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med (2012) 1.39
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Genet Med (2011) 1.37
Horizon scanning for new genomic tests. Genet Med (2011) 1.36
The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med (2006) 1.35
Conclusion and future directions: CDC Health Disparities and Inequalities Report - United States, 2013. MMWR Surveill Summ (2013) 1.34
Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States - 2009-2013. MMWR Morb Mortal Wkly Rep (2015) 1.33
Personal utility and genomic information: look before you leap. Genet Med (2009) 1.32
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med (2012) 1.32
Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics (2008) 1.31
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst (2010) 1.30
Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diabetes Care (2005) 1.28
Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med (2010) 1.27
Diabetes - United States, 2004 and 2008. MMWR Surveill Summ (2011) 1.27
Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care (2003) 1.26
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention. Am J Med Genet C Semin Med Genet (2004) 1.25
Predictive genetic testing for type 2 diabetes. BMJ (2006) 1.24
An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology. BMC Bioinformatics (2007) 1.24
Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999-2006. Ann Fam Med (2010) 1.21
Lexicon, definitions, and conceptual framework for public health surveillance. MMWR Surveill Summ (2012) 1.20
Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev (2012) 1.19
Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet Med (2007) 1.18